GABA B receptor-positive modulators: Enhancement of GABA B receptor agonist effects in vivo

Journal of Pharmacology and Experimental Therapeutics

Volumn 335, Issue 1, 2010, Pages 163-171

  Koek, Wouter ^a   France, Charles P ^a   Cheng, Kejun ^b   Rice, Kenner C ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,6 DI TERT BUTYL 4 (3 HYDROXY 2,2 DIMETHYLPROPYL)PHENOL; 3 AMINOPROPYL(DIETHOXYMETHYL)PHOSPHINIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR STIMULATING AGENT; 5,7 DI TERT BUTYL 3 HYDROXY 3 TRIFLUOROMETHYL 3H BENZOFURAN 2 ONE; UNCLASSIFIED DRUG; (R,S) 5,7 DI TERT BUTYL 3 HYDROXY 3 TRIFLUOROMETHYL 3H BENZOFURAN 2 ONE; (R,S)-5,7-DI-TERT-BUTYL-3-HYDROXY-3-TRIFLUOROMETHYL-3H-BENZOFURAN-2-ONE; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; BACLOFEN; BENZOFURAN DERIVATIVE; ENZYME INHIBITOR; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; ORGANOPHOSPHORUS COMPOUND; OXYBATE SODIUM; PHENOL DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENCY; DRUG RECEPTOR BINDING; HYPOTHERMIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BODY TEMPERATURE; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; DRUG POTENTIATION;

ANIMALS; BACLOFEN; BENZOFURANS; BODY TEMPERATURE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GABA AGONISTS; GABA ANTAGONISTS; HYPOTHERMIA; MALE; MICE; MICE, INBRED C57BL; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; ORGANOPHOSPHORUS COMPOUNDS; PHENOLS; RECEPTORS, GABA-B; SODIUM OXYBATE;

EID: 77957231822     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.110.171116     Document Type: Article

References (47)

1. Adams CL and Lawrence AJ (2007) CGP7930: a positive allosteric modulator of the GABAB receptor. CNS Drug Rev 13:308-316.
2. Addolorato G, Leggio L, Cardone S, Ferrulli A, and Gasbarrini G (2009) Role of the GABA(B) receptor system in alcoholism and stress: focus on clinical studies and treatment perspectives. Alcohol 43:559-563.
3. Arunlakshana O and Schild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol Chemother 14:48-58.
4. Binet V, Brajon C, Le Corre L, Acher F, Pin JP, and Prézeau L (2004) The heptahelical domain of GABA(B2) is activated directly by CGP7930, a positive allosteric modulator of the GABA(B) receptor. J Biol Chem 279:29085-29091.
5. Carai MA, Colombo G, Froestl W, and Gessa GL (2004) In vivo effectiveness of CGP7930, a positive allosteric modulator of the GABAB receptor. Eur J Pharmacol 504:213-216.
6. Carai MA, Lobina C, Maccioni P, Cabras C, Colombo G, and Gessa GL (2008) γ-Aminobutyric acid B (GABAB)-receptor mediation of different in vivo effects of gamma-butyrolactone. J Pharmacol Sci 106:199-207.
7. Carter LP, Chen W, Coop A, Koek W, and France CP (2006) Discriminative stimulus effects of GHB and GABA(B) agonists are differentially attenuated by CGP35348. Eur J Pharmacol 538:85-93.
8. Carter LP, Koek W, and France CP (2009) Behavioral analyses of GHB: receptor mechanisms. Pharmacol Ther 121:100-114.
9. Carter LP, Wu H, Chen W, Matthews MM, Mehta AK, Hernandez RJ, Thomson JA, Ticku MK, Coop A, Koek W, et al. (2005) Novel γ-hydroxybutyric acid (GHB) analogs share some, but not all, of the behavioral effects of GHB and GABAB receptor agonists. J Pharmacol Exp Ther 313:1314-1323.
10. Chen Y, Menendez-Roche N, and Sher E (2006) Differential modulation by the GABAB receptor allosteric potentiator 2,6-di-tert-butyl-4-(3-hydroxy-2,2- dimethylpropyl)-phenol (CGP7930) of synaptic transmission in the rat hippocampal CA1 area. J Pharmacol Exp Ther 317:1170-1177.
11. Christopoulos A (2002) Allosteric binding sites on cell-surface receptors: novel targets for drug discovery. Nat Rev Drug Discov 1:198-210.
12. Conn PJ, Christopoulos A, and Lindsley CW (2009) Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders. Nat Rev Drug Discov 8:41-54.
13. Cryan JF, Kelly PH, Chaperon F, Gentsch C, Mombereau C, Lingenhoehl K, Froestl W, Bettler B, Kaupmann K, and Spooren WP (2004) Behavioral characterization of the novel GABAB receptor-positive modulator GS39783 (N,N′-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): anxiolytic-like activity without side effects associated with baclofen or benzodiazepines. J Pharmacol Exp Ther 310:952-963.
14. Filip M, Frankowska M, and Przegaliński E (2007) Effects of GABA(B) receptor antagonist, agonists and allosteric positive modulator on the cocaine-induced self-administration and drug discrimination. Eur J Pharmacol 574:148-157.
15. Frankowska M, Filip M, and Przegaliński E (2007) Effects of GABAB receptor ligands in animal tests of depression and anxiety. Pharmacol Rep 59:645-655. (Pubitemid 351586555)
16. Gray JA, Goodwin GM, Heal DJ, and Green AR (1987) Hypothermia induced by baclofen, a possible index of GABAB receptor function in mice, is enhanced by antidepressant drugs and ECS. Br J Pharmacol 92:863-870.
17. Jacobson LH and Cryan JF (2005) Differential sensitivity to the motor and hypothermic effects of the GABA B receptor agonist baclofen in various mouse strains. Psychopharmacology (Berl) 179:688-699.
18. Jacobson LH and Cryan JF (2008) Evaluation of the anxiolytic-like profile of the GABAB receptor positive modulator CGP7930 in rodents. Neuropharmacology 54:854-862.
19. Kaupmann K, Cryan JF, Wellendorph P, Mombereau C, Sansig G, Klebs K, Schmutz M, Froestl W, van der Putten H, Mosbacher J, et al. (2003) Specific γ-hydroxybutyrate-binding sites but loss of pharmacological effects of γ-hydroxybutyrate in GABA(B)(1)-deficient mice. Eur J Neurosci 18:2722-2730.
20. Kenakin T (1997) Competitive antagonism, in Pharmacologic Analysis of Drug-Receptor Interaction, 3rd ed, pp 331-373, Lippincott-Raven, Philadelphia, PA.
21. Kerr DI and Ong J (1995) GABAB receptors. Pharmacol Ther 67:187-246.
22. Koek W and France CP (2008) Cataleptic effects of γ-hydroxybutyrate (GHB) and baclofen in mice: mediation by GABA(B) receptors, but differential enhancement by N-methyl-D-aspartate (NMDA) receptor antagonists. Psychopharmacology (Berl) 199:191-198.
23. Koek W, Flores LR, Carter LP, Lamb RJ, Chen W, Wu H, Coop A, and France CP (2004) Discriminative stimulus effects of γ-hydroxybutyrate in pigeons: role of diazepam-sensitive and -insensitive GABA(A) and GABA(B) receptors. J Pharmacol Exp Ther 308:904-911.
24. Koek W, Khanal M, and France CP (2007a) Synergistic interactions between 'club drugs': γ-hydroxybutyrate and phencyclidine enhance each other's discriminative stimulus effects. Behav Pharmacol 18:807-810.
25. Koek W, Mercer SL, and Coop A (2007b) Cataleptic effects of γ-hydroxybutyrate (GHB), its precursor γ-butyrolactone (GBL), and GABAB receptor agonists in mice: differential antagonism by the GABAB receptor antagonist CGP35348. Psychopharmacology (Berl) 192:407-414.
26. Koek W, Mercer SL, Coop A, and France CP (2009) Behavioral effects of γ-hydroxybutyrate, its precursor γ-butyrolactone, and GABA(B) receptor agonists: time course and differential antagonism by the GABA(B) receptor antagonist 3-aminopropyl(diethoxymethyl)phosphinic acid (CGP35348). J Pharmacol Exp Ther 330:876-883.
27. Liang JH, Chen F, Krstew E, Cowen MS, Carroll FY, Crawford D, Beart PM, and Lawrence AJ (2006) The GABA(B) receptor allosteric modulator CGP7930, like baclofen, reduces operant self-administration of ethanol in alcohol-preferring rats. Neuropharmacology 50:632-639.
28. Maccioni P, Carai MA, Kaupmann K, Guery S, Froestl W, Leite-Morris KA, Gessa GL, and Colombo G (2009) Reduction of alcohol's reinforcing and motivational properties by the positive allosteric modulator of the GABA(B) receptor, BHF177, in alcohol-preferring rats. Alcohol Clin Exp Res 33:1749-1756.
29. Maccioni P, Fantini N, Froestl W, Carai MA, Gessa GL, and Colombo G (2008) Specific reduction of alcohol's motivational properties by the positive allosteric modulator of the GABAB receptor, GS39783-comparison with the effect of the GABAB receptor direct agonist, baclofen. Alcohol Clin Exp Res 32:1558-1564.
30. Malherbe P, Masciadri R, Norcross RD, Knoflach F, Kratzeisen C, Zenner MT, Kolb Y, Marcuz A, Huwyler J, Nakagawa T, et al. (2008) Characterization of (R,S)-5,7-di-tert-butyl-3-hydroxy-3-trifluoromethyl-3H-benzofuran-2-one as a positive allosteric modulator of GABAB receptors. Br J Pharmacol 154:797-811.
31. Markou A, Paterson NE, and Semenova S (2004) Role of γ-aminobutyric acid (GABA) and metabotropic glutamate receptors in nicotine reinforcement: potential pharmacotherapies for smoking cessation. Ann NY Acad Sci 1025:491-503.
32. Mathivet P, Bernasconi R, De Barry J, Marescaux C, and Bittiger H (1997) Binding characteristics of γ-hydroxybutyric acid as a weak but selective GABAB receptor agonist. Eur J Pharmacol 321:67-75.
33. Mombereau C, Lhuillier L, Kaupmann K, and Cryan JF (2007) GABAB receptor-positive modulation-induced blockade of the rewarding properties of nicotine is associated with a reduction in nucleus accumbens DeltaFosB accumulation. J Pharmacol Exp Ther 321:172-177.
34. Orrù A, Lai P, Lobina C, Maccioni P, Piras P, Scanu L, Froestl W, Gessa GL, Carai MA, and Colombo G (2005) Reducing effect of the positive allosteric modulators of the GABA(B) receptor, CGP7930 and GS39783, on alcohol intake in alcoholpreferring rats. Eur J Pharmacol 525:105-111.
35. Parker DA, Marino V, Ong J, Puspawati NM, and Prager RH (2008) The CGP7930 analogue 2,6-di-tert-butyl-4-(3-hydroxy-2-spiropentylpropyl)-phenol (BSPP) potentiates baclofen action at GABA(B) autoreceptors. Clin Exp Pharmacol Physiol 35:1113-1115.
36. Paterson NE, Vlachou S, Guery S, Kaupmann K, Froestl W, and Markou A (2008) Positive modulation of GABA(B) receptors decreased nicotine self-administration and counteracted nicotine-induced enhancement of brain reward function in rats. J Pharmacol Exp Ther 326:306-314.
37. Pilc A and Nowak G (2005) GABAergic hypotheses of anxiety and depression: focus on GABA-B receptors. Drugs Today (Barc) 41:755-766.
38. Pin JP and Prézeau L (2007) Allosteric modulators of GABA(B) receptors: mechanism of action and therapeutic perspective. Curr Neuropharmacol 5:195-201.
39. -/- mice. Br J Pharmacol 140:315-322.
40. Rawls SM, Baron DA, Gomez T, Jacobs K, and Tallarida RJ (2004) Pronounced hypothermic synergy between systemic baclofen and NOS inhibitor. Eur J Pharmacol 502:271-272.
41. Rawls SM, Jacobs K, and Tallarida RJ (2006) Baclofen and NOS inhibitors interact to evoke synergistic hypothermia in rats. Life Sci 78:669-672. (Pubitemid 41821122)
42. Tallarida RJ (2000) Dose-response analysis, in Drug Synergism and Dose-Effect Data Analysis, pp 44-50, Chapman & Hall/CRC, Boca Raton, FL.
43. Urwyler S, Gjoni T, Koljatić J, and Dupuis DS (2005) Mechanisms of allosteric modulation at GABAB receptors by CGP7930 and GS39783: effects on affinities and efficacies of orthosteric ligands with distinct intrinsic properties. Neuropharmacology 48:343-353. (Pubitemid 40249997)
44. Urwyler S, Mosbacher J, Lingenhoehl K, Heid J, Hofstetter K, Froestl W, Bettler B, and Kaupmann K (2001) Positive allosteric modulation of native and recombinant γ-aminobutyric acid(B) receptors by 2,6-di-tert-butyl-4-(3- hydroxy-2,2-dimethylpropyl)-phenol (CGP7930) and its aldehyde analog CGP13501. Mol Pharmacol 60:963-971.
45. Urwyler S, Pozza MF, Lingenhoehl K, Mosbacher J, Lampert C, Froestl W, Koller M, and Kaupmann K (2003) N,N′-dicyclopentyl-2-methylsulfanyl-5- nitro-pyrimidine-4,6-diamine (GS39783) and structurally related compounds: novel allosteric enhancers of γ-aminobutyric acidB receptor function. J Pharmacol Exp Ther 307:322-330.
46. van Nieuwenhuijzen PS and McGregor IS (2009) Sedative and hypothermic effects of γ-hydroxybutyrate (GHB) in rats alone and in combination with other drugs: assessment using biotelemetry. Drug Alcohol Depend 103:137-147.
47. Wang L, Martin B, Brenneman R, Luttrell LM, and Maudsley S (2009) Allosteric modulators of G protein-coupled receptors: future therapeutics for complex physiological disorders. J Pharmacol Exp Ther 331:340-348.